CHEMPHARMA Limited Liability Company (hereinafter referred to as the “Data Controller”) is committed to protecting personal data. The purpose of this Privacy Policy is to provide transparent information about how personal data is collected, processed and stored when using the website.
During data processing, the Data Controller fully complies with Regulation (EU) 2016/679 of the European Parliament and of the Council (GDPR) and the applicable Hungarian legal regulations.
Company name: CHEMPHARMA Limited Liability Company
Registered office: 2040 Budaörs, Otthon utca 7. II.
floor 10.
Managing Director: Tibor Papp
Email:
studio@bravenewworld.hu
Website:
https://bravenewworld.hu
Hostinger International Ltd.
Address: 61 Lordou Vironos Street, 6023 Larnaca, Cyprus
Website:
https://www.hostinger.com
Contact:
support@hostinger.com
Legal basis: GDPR Article 6(1)(b)
The website provides the possibility to initiate appointment bookings. Appointment bookings are technically handled on the Data Controller’s own website or on a booking system operated by the Data Controller. Personal data provided during the booking process is processed solely for the purpose of managing the appointment and maintaining contact.
Legal basis: GDPR Article 6(1)(b)
Legal basis: GDPR Article 6(1)(a) – consent
Legal basis: GDPR Article 6(1)(c)
The Data Controller applies appropriate technical and organizational measures to protect personal data against unauthorized access, loss, destruction or alteration.
If you believe that your personal data has been processed unlawfully, you may lodge a complaint with the following authority:
National Authority for Data Protection and Freedom of Information
(NAIH)
Falk Miksa utca 9–11., 1055 Budapest, Hungary
www.naih.hu
For any questions regarding data processing:
📧
studio@bravenewworld.hu
For the operation of the website, the Data Controller uses Hostinger International Ltd. as a data processor. Personal data is transferred to third parties only where required by law or based on the data subject’s consent.
Effective date: January 2026
CHEMPHARMA Limited Liability Company (hereinafter referred to as the “Data Controller”) is committed to protecting personal data. The purpose of this Privacy Policy is to provide transparent information about how personal data is collected, processed and stored when using the website.
During data processing, the Data Controller fully complies with Regulation (EU) 2016/679 of the European Parliament and of the Council (GDPR) and the applicable Hungarian legal regulations.
Company name: CHEMPHARMA Limited Liability Company
Registered office: 2040 Budaörs, Otthon utca 7. II.
floor 10.
Managing Director: Tibor Papp
Email:
studio@bravenewworld.hu
Website:
https://bravenewworld.hu
Hostinger International Ltd.
Address: 61 Lordou Vironos Street, 6023 Larnaca, Cyprus
Website:
https://www.hostinger.com
Contact:
support@hostinger.com
Legal basis: GDPR Article 6(1)(b)
The website provides the possibility to initiate appointment bookings. Appointment bookings are technically handled on the Data Controller’s own website or on a booking system operated by the Data Controller. Personal data provided during the booking process is processed solely for the purpose of managing the appointment and maintaining contact.
Legal basis: GDPR Article 6(1)(b)
Legal basis: GDPR Article 6(1)(a) – consent
Legal basis: GDPR Article 6(1)(c)
The Data Controller applies appropriate technical and organizational measures to protect personal data against unauthorized access, loss, destruction or alteration.
If you believe that your personal data has been processed unlawfully, you may lodge a complaint with the following authority:
National Authority for Data Protection and Freedom of Information
(NAIH)
Falk Miksa utca 9–11., 1055 Budapest, Hungary
www.naih.hu
For any questions regarding data processing:
📧
studio@bravenewworld.hu
For the operation of the website, the Data Controller uses Hostinger International Ltd. as a data processor. Personal data is transferred to third parties only where required by law or based on the data subject’s consent.
Effective date: January 2026